GlassScriptPhysician profile
Morlee Burgess
NPI 1821386525
$4,301.62
in general payments reported to CMS, 2019-2025
47 companies · $687 in 2025
The $687 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $388 · 2021: $860 · 2022: $349 · 2023: $689 · 2024: $981 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,357.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,306.17 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $703.56 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $263.43 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $196.05 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $165.84 | 2019-2023 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $153.93 | 2020-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $109.95 | 2019-2025 | |
| Welch Allyn | $107.56 | 2021 | |
| Hologic Sales and Service, LLC | $100.42 | 2021-2025 | Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.30 | 2019-2023 | Trulance, Xifaxan |
| Dexcom, INC. | $84.04 | 2020-2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $71.58 | 2023-2025 | Veozah, Myrbetriq |
| Eisai INC. | $60.37 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $55.30 | 2023-2024 | Gemtesa |
| Exact Sciences Corporation | $47.51 | 2024-2025 | Cologuard Collection Kit |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morlee Burgess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.